Why is XERS Down Today?
About Xeris Biopharma Holdings, Inc. Common Stock
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia,...
Overall Confidence: 50%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.5%
Market Comparison
🔔 Get XERS Alerts
We'll notify you when XERS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
XERS has moved more than 3.0% down on 30 occasions in the past year.
Frequently Asked Questions
Why is XERS stock down today?
XERS is down 3.1% today on 0.6x average volume. The move appears to be driven by general market sentiment and momentum traders.
Is XERS stock a buy or sell right now?
Based on current analysis, XERS shows 50% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the XERS stock price target?
XERS is currently trading at $7.43. Based on today's momentum, the expected short-term range is $7.21 - $7.58. See long-term price prediction →
Will XERS stock continue falling?
Our analysis shows a 45% probability that XERS's move continues in the next 1-3 days. Key level to watch: $7.06 (support).
Is XERS stock oversold or overbought?
XERS's RSI (Relative Strength Index) is currently at 30.0. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for XERS stock?
XERS's 10-day momentum indicator is at -1.15. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is XERS outperforming or underperforming the market?
XERS (-3.13%) is currently significantly underperforming the market (-4.0% vs SPY). Today, the S&P 500 (SPY) is up 0.85%, and Nasdaq (QQQ) is up 0.87%.
What does MACD indicate for XERS?
XERS's MACD (-0.11) is currently below the signal line (0.03), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 18.4) is weak.
Is XERS in an uptrend or downtrend?
Based on moving average analysis, XERS is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $8.46, 50-day SMA: $8.4.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis